Search / Trial NCT06230263

Comparative Functional Vision Outcomes: DAILIES TOTAL1 Toric vs. Spherical Lenses in Asian Astigmatic Patients

Launched by MOPSY RESEARCH · Jan 19, 2024

Trial Information

Current as of December 30, 2024

Recruiting

Keywords

Astigmatism Toric Contact Lenses Contact Lens Satisfaction Digital Device Usage

ClinConnect Summary

This clinical trial is looking at how well DAILIES TOTAL1 Toric Contact Lenses work compared to Spherical Equivalent Contact Lenses for people with astigmatism, particularly focusing on Asian individuals who often use digital devices like smartphones and computers. The study aims to understand how these lenses affect daily vision quality, especially during screen use, and to evaluate how comfortable and satisfied participants feel while wearing each type of lens.

To join the trial, participants should be Asian, between 18 and 39 years old, and have specific vision requirements. They should have been wearing soft contact lenses for at least six months and have good vision with correction. During the study, participants will wear both types of lenses for a set time, perform tasks involving digital screens, and share their experiences regarding comfort and satisfaction. This trial is currently recruiting and aims to gather valuable information to help improve vision care for astigmatic patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Self-identified as Asian, confirmed through both self-report and observation by the Principal Investigator (PI).
  • Age between 18 and 39 years.
  • Vertexed corrected sphere power ranging from -0.50 to -6.00 diopters (D).
  • Vertexed refractive cylinder power ranging from -0.75 to -1.50 diopters (D).
  • Best corrected visual acuity of 20/25 or better in each eye.
  • Habitual soft contact lens wear for at least 6 months and must be successfully fitted with both DT1 Spherical and Toric contact lenses.
  • Exclusion Criteria:
  • Any history of ocular pathology or surgery.
  • Presence of active ocular infection or clinically significant ocular inflammation.
  • Presence of any significant binocular vision abnormalities.
  • Use of gas-permeable contact lenses within 3 months prior to the study.
  • Pregnancy or lactation, confirmed by self-report.

Trial Officials

MANKI CHAN

Principal Investigator

Mopsy Research

About Mopsy Research

Mopsy Research is a leading clinical trial sponsor dedicated to advancing medical innovation through rigorous research and development. With a focus on enhancing patient outcomes, Mopsy Research collaborates with healthcare professionals and institutions to design and execute high-quality clinical trials across various therapeutic areas. Our commitment to scientific integrity and ethical standards ensures that we contribute meaningful insights to the medical community, ultimately fostering the development of safe and effective treatments. Through our state-of-the-art methodologies and a patient-centered approach, Mopsy Research is at the forefront of transforming healthcare solutions for the benefit of patients worldwide.

Locations

Hong Kong, , Hong Kong

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0